期刊文献+

聚合酶链反应和反向斑点杂交技术检测人乳头瘤病毒感染 被引量:1

Application value of PCR and RDB in detecting HPV infection
下载PDF
导出
摘要 目的:研究聚合酶链反应(polymerase chain reaction,PCR)和反向斑点杂交(reverse dot blot,RDB)技术在人乳头瘤病毒(human papillomavirus,HPV)感染检测中的情况,进一步研究其应用价值。方法:收集2013年3月至2015年6月宫颈癌、尖锐湿疣、宫颈上皮内瘤变三种类型疾病共320例脱落细胞标本,采用PCR和RDB杂交技术对HPV基因型进行检测,分析检测数据。结果:在宫颈癌、尖锐湿疣、宫颈上皮内瘤变的感染中HPV单基因型感染均多于多重基因型感染,但不同疾病中单基因型感染患者比率差别不明显,分别为82.50%、84.06%、84.30%;不同疾病中多重基因型感染患者例数分别为17.50%、15.94%、15.70%,两种类型感染情况比较,差异无统计学意义(P>0.05);320例标本中检测出的210例阳性标本进行分型,反复检验后数据显示HPV16为最主要的感染基因型。结论:PCR和RDB技术是HPV基因型检测的有效方法,也是关于进行HPV感染防治的有效检测指标。 Objective:To study the value of polymerase chain reaction( PCR) and reverse dot blot( RDB) in the detection of human papillomavirus( HPV) infection. Methods:320 exfoliative cells samples of cervical cancer,condyloma acuminatum,and cervical intraepithelial neoplasia from March 2013 to June 2015 were collected and the HPV genotype was detected by PCR and RDB. Results:The HPV haplotype infection rates in cervical cancer,condyloma acuminatum,and cervical intraepithelial neoplasia were higher than the infection rates in multiple genotypes. The HPV haplotype infection rates were 82. 50 %,84. 06 % and 84. 30 % respectively and in multiple genotypes were 17. 50 %,15. 94 % and15. 70 % respectively. There was no significant difference of infection in each group( P〈0. 05). HPV16 was the most common infection genotype in the 210 positive samples after repeated detection. Conclusion:PCR and RDP are effective methods in the detection of HPV genotype as well as in HPV prevention and treatment.
出处 《包头医学院学报》 CAS 2017年第2期29-30,共2页 Journal of Baotou Medical College
关键词 基因分型 聚合酶链反应 反向斑点杂交技术 人类乳头瘤病毒 Genotyping Polymerase chain reaction(PCR) Reverse dot blotting(RDB) Human papillomavirus(HPV)
  • 相关文献

参考文献1

二级参考文献10

  • 1魏丽惠.应高度关注子宫颈病变的筛查[J].中国医刊,2007,42(8):2-5. 被引量:27
  • 2Parkin DM. The slobal health burden of infection - associatedcancers in the year 2002[ J]. Int J Cancer, 2006,118(12) : 3030.
  • 3Kuhn L, Denny L,Pollack A, et al. Human papillomavirusDNA testing for cervical cancer screening in low resource set-tings [J]. J Natl Cancer Inst,2000, 92 (10): 818.
  • 4Wright TC,Cox JT,Massad S,et al. 2001 Consensus guide-lines for the management of women with cervical intraepithelialneoplasia[ J]. J Low Genit Tract Dis,2003,1 ( 89 ):295.
  • 5Naucler P,Ryd W,Tomberg S et al. HPV type - specific risks ofhish — grade CIN during 4 years of follow - up : a population —based prospective study[ J]. Br J Cancer,2007,97:129.
  • 6De Cremoux P, Coste J, Sastre - Garau X,et al. Efficiencyof the hybrid capture 2 HPV DNA test in cervical can cerscreening. A study by the French Society of Clinical Cytology[J] . Am J Clin Pathol, 2003,120 (4) : 492-9.
  • 7Tsai HJ, Wu CH, Lai HL,et al. Association between quanti-tative high - risk human papillomavirus DNA load and cervicalintraepithelial neoplasm risk[J]. Cancer Epidemiol Biomark-ers Prev, 2005,14 (11) : 2544.
  • 8Bekkers RL,Massuger LF, Buhen J, et al. Epidemiologicaland clinical aspects of human papillomavirus detection in theprevention of cervical cancer [ J ] . Rev Med Virol, 2004,14: 95.
  • 9Schifman MH,Bauer HM,Hoover RN, et al. Epidemiologyof cervical cacinogenisis[J]. Cancer, 1995,76: 1888.
  • 10ZurHausen H. Papillomavirus causing cancer : Evasion fromhost - cell control in early events in carcinogenesis[ J]. JNatl Cancer Inst,2000,92: 690.

共引文献55

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部